Stock listing

LEXX Stock Price, News, Filings & Events — Lexaria Bioscience Corp.

Selected listing: LEXX · NASDAQ · USD · US

This page tracks Lexaria Bioscience Corp.'s LEXX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LEXX:NASDAQ. LEXX:NASDAQ is the stock-level entry point for investors researching Lexaria Bioscience Corp., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lexaria Bioscience Corp. (Ticker: LEXX) is a public company based in the United States, with a market capitalization of approximately $13.86 million. The company focuses on developing innovative drug delivery technologies, particularly in the field of cannabinoid delivery. Lexaria aims to enhance the bioavailability and effectiveness of various compounds through its proprietary methods.